Related Experiment Video
Updated: Feb 16, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome
Jenna Janiga1, Jonathan Kentley2, Chadi Nabhan3
1a Stritch School of Medicine , Loyola University , Chicago , IL , USA.
Abstract:
Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common cutaneous T-cell lymphomas (CTCLs). Both lack curative options, and advanced-stage carries a poor prognosis. Whilst there are a number of treatments available, achieving and maintaining a durable remission remains challenging. We review current systemic treatment options as monotherapy for advanced-stage MF (IIB-IV), appraising their mechanism of action, analyzing their efficacy, and describing toxicities. Individually, reported overall response rates (ORR) vary widely in the literature and duration of responses are typically short, ranging from 7.5 to 22.4 months. Combined therapy is frequently used in an effort to boost responses, although prospective studies comparing combinations to single agent therapies are rarely conducted. While recent translational research has led to increased understanding of the immunopathogenesis of MF and SS and the development of new treatments, current standard of care therapies are not curative and have low ORR for advanced-stage disease.
Insights
Current treatments for advanced cutaneous T-cell lymphomas like mycosis fungoides and Sézary syndrome offer limited durable remission. Research into new therapies is ongoing, but standard options remain non-curative with low response rates.
Area of Science:
- Oncology
- Dermatology
- Immunology
Background:
- Mycosis fungoides (MF) and Sézary syndrome (SS) are the most prevalent cutaneous T-cell lymphomas (CTCLs).
- Advanced-stage CTCLs lack curative treatments and are associated with a poor prognosis.
- Achieving durable remission with current therapies remains a significant clinical challenge.
Purpose of the Study:
- To review current systemic monotherapy options for advanced-stage MF (IIB-IV).
- To analyze the efficacy, mechanism of action, and toxicities of existing treatments.
- To highlight the limitations of current standard of care in achieving durable responses.
Main Methods:
- Literature review of systemic monotherapy for advanced-stage MF.
- Appraisal of treatment mechanisms, efficacy (overall response rates - ORR), and toxicity profiles.
- Analysis of reported response durations, typically ranging from 7.5 to 22.4 months.
Main Results:
- Reported ORR for individual therapies vary widely across studies.
- Duration of responses to current monotherapies is generally short.
- Combined therapies are used but lack robust comparative prospective studies against monotherapy.
Conclusions:
- Current standard of care therapies for advanced-stage MF and SS are not curative.
- Despite advances in understanding immunopathogenesis, existing treatments have low ORR and limited durability.
- There is a critical need for novel, curative therapeutic strategies for advanced CTCLs.
More Related Videos
06:54Author Spotlight: Advances in Nanoscale Infrared Spectroscopy to Explore Multiphase Polymeric Systems
Published on: June 23, 2023
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Related Concept Videos
Therapeutic Index
Electrical Current
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Second Order systems II
Extraction: Advanced Methods
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...